DRD2 and schizophrenia: The subsequent demonstration that potency of antipsychotic drugs to block dopamine D2 receptors correlates with their effective clinical doses [4] provided credibility to the excess of dopaminergic activity as an underlying mechanism of psychosis in schizophrenia.